Our Technology

At Eliaz Therapeutics, we have developed a patented and innovative medical device specifically designed to remove Galectin-3 (Gal-3) from human blood.

This device, effectively eliminates Gal-3 from the circulation, offering a much needed solution where there is none.

This device, effectively eliminates Gal-3 from the circulation, offering a much needed solution where there is none.

This device, effectively eliminates Gal-3 from the circulation, offering a much needed solution where there is none.

What is Gal-3?

Our solution

How it works

Scientist wearing safety goggles and blue lab attire, using a pipette to transfer liquid into a vial in a laboratory setting.

The Overlooked Protein Fueling Some of the Deadliest Diseases

Galectin-3 (Gal-3) is a protein made by the body in response to stress, injury, and aging. In healthy amounts, it plays a normal role in cell repair.

But when Gal-3 levels rise too high, they trigger a cascade of harmful inflammation—and are now linked to some of the most dangerous conditions in medicine such as sepsis, kidney disease, fibrosis, & cancer progression.

Over 10,000 peer-reviewed studies have identified Gal-3 as a key driver of disease—and until now, there’s been no effective way to remove it.

What is Gal-3?

Our solution

How it works

Scientist wearing safety goggles and blue lab attire, using a pipette to transfer liquid into a vial in a laboratory setting.

The Overlooked Protein Fueling Some of the Deadliest Diseases

Galectin-3 (Gal-3) is a protein made by the body in response to stress, injury, and aging. In healthy amounts, it plays a normal role in cell repair.

But when Gal-3 levels rise too high, they trigger a cascade of harmful inflammation—and are now linked to some of the most dangerous conditions in medicine such as sepsis, kidney disease, fibrosis, & cancer progression.

Over 10,000 peer-reviewed studies have identified Gal-3 as a key driver of disease—and until now, there’s been no effective way to remove it.

What is Gal-3?

Our solution

How it works

Scientist wearing safety goggles and blue lab attire, using a pipette to transfer liquid into a vial in a laboratory setting.

The Overlooked Protein Fueling Some of the Deadliest Diseases

Galectin-3 (Gal-3) is a protein made by the body in response to stress, injury, and aging. In healthy amounts, it plays a normal role in cell repair.

But when Gal-3 levels rise too high, they trigger a cascade of harmful inflammation—and are now linked to some of the most dangerous conditions in medicine such as sepsis, kidney disease, fibrosis, & cancer progression.

Over 10,000 peer-reviewed studies have identified Gal-3 as a key driver of disease—and until now, there’s been no effective way to remove it.

Proof of Concept Results

Proof of Concept Results

Proof of Concept Results

Our groundbreaking Proof of Concept began with a large animal study, where our device demonstrated a remarkable ability to reduce inflammation and fibrosis. The visual evidence below highlights the difference between control and experimental groups. These compelling results were published in a peer-reviewed journal by MGH Harvard.

Further POC results from septic large-animal studies can be shared under confidentiality.

$1.9m+

Funding secured for product development projects

$1.9m+

Funding secured for product development projects

$1.9m+

Funding secured for product development projects

Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.
Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.
Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.

Latest News

Latest News

Latest News

The content on this website is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Our product(s) are in development, not approved for commercial use, and not available for sale. Any forward-looking statements reflect current plans and expectations, which may change. If you choose to visit our crowdfunding campaign, please be aware that investing involves risk and should not be considered a guarantee of future outcomes. Mention of third-party organizations does not imply affiliation unless explicitly stated. All trademarks, logos, and technologies referenced are the property of Eliaz Therapeutics or its licensors and may not be used without written permission.

The content on this website is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Our product(s) are in development, not approved for commercial use, and not available for sale. Any forward-looking statements reflect current plans and expectations, which may change. If you choose to visit our crowdfunding campaign, please be aware that investing involves risk and should not be considered a guarantee of future outcomes. Mention of third-party organizations does not imply affiliation unless explicitly stated. All trademarks, logos, and technologies referenced are the property of Eliaz Therapeutics or its licensors and may not be used without written permission.

The content on this website is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Our product(s) are in development, not approved for commercial use, and not available for sale. Any forward-looking statements reflect current plans and expectations, which may change. If you choose to visit our crowdfunding campaign, please be aware that investing involves risk and should not be considered a guarantee of future outcomes. Mention of third-party organizations does not imply affiliation unless explicitly stated. All trademarks, logos, and technologies referenced are the property of Eliaz Therapeutics or its licensors and may not be used without written permission.